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ABSTRACT
We have previously reported that innervation-dependent basal
contractile activity regulates in an inverse manner the expression of
GLUT1 and GLUT4 glucose transporters in skeletal muscle. Based on
the facts that muscle innervation decreases and muscle denervation
increases cAMP levels, we investigated whether cAMP might mediate
the effects of innervation/denervation on glucose transporter expres-
sion. Treatment of L6E9 myotubes with 8-bromo-cAMP, forskolin, or
monobutyryl-8-bromo-cAMP led to a marked decrease in GLUT4 pro-
tein levels; 8-bromo-cAMP also diminished GLUT4 messenger RNA
(mRNA), suggesting pretranslational repression. In contrast, L6E9
myoblasts and myotubes responded to 8-bromo-cAMP or forskolin by
increasing the cell content of GLUT1 protein. Induction of GLUT1
protein was a consequence of the activation of different mechanisms
in myoblast and myotube cells; whereas 8-bromo-cAMP treatment
caused a substantial increase in GLUT1 mRNA in myoblasts, no
change in GLUT1 mRNA was detected in myotubes. The increase in
GLUT1 mRNA in L6E9 myoblasts induced by 8-bromo-cAMP was the
result of transcriptional activation, as concluded from transfection
analysis of 2.1 kilobases of the rat GLUT1 gene promoter fused to the
bacterial chloramphenicol acetyltransferase gene. Furthermore, the
stimulatory effect of 8-bromo-cAMP on the transcriptional activity of
the GLUT1 promoter required a 33-bp sequence lying 59 upstream of
the transcription start site. In all, cAMP inversely regulates GLUT4
and GLUT1 glucose transporter expression in muscle cells. Further-
more, our results suggest that down-regulation of GLUT4 expression
and up-regulation of GLUT1 expression in muscle associated with
denervation are partly attributable to cAMP. (Endocrinology 138:
2521–2529, 1997)
SKELETAL MUSCLE is the main tissue responsible forinsulin-induced glucose utilization in humans and ro-
dents (1, 2), and glucose transport in this tissue is rate limiting
for glucose disposal under most physiological conditions (3).
Skeletal muscle expresses both GLUT4 and GLUT1 glucose
transporters (4, 5) in a highly regulatable manner. Strepto-
zotocin-induced diabetes leads to a reduction of GLUT4 ex-
pression (6–8), which seems to affect red and white muscle
in different ways (9). Experimental models of type II diabe-
tes, such as the Zucker diabetic rat or the SHR/N-cp diabetic
rat, also display a reduction of GLUT4 expression in skeletal
muscle (10–12).
The expression of GLUT1 and GLUT4 genes in skeletal
muscle and heart is also developmentally regulated (13–15).
Thus, during fetal and early postnatal life, GLUT1 is the
predominant glucose transporter expressed in muscle (14).
Postnatal life is characterized by GLUT1 repression in muscle
concomitant with an increase in GLUT4 expression (14). The
expression of glucose transporter isoforms during perinatal
life fits well with the observations of a high rate of glucose
uptake by fetal and early neonatal rat heart and diaphragm
(16, 17) and a moderate stimulatory effect of insulin on glu-
cose transport by early neonatal diaphragm (17). Regarding
the nature of the factors that trigger GLUT4 induction and
GLUT1 repression during perinatal development, it has been
reported that perinatal hypothyroidism greatly impairs the
normal transition of GLUT4 and GLUT1 glucose transporters
from fetal to neonatal levels in heart (18), suggesting that
thyroid hormones play a critical role in the regulation of
glucose carriers during perinatal life in muscle tissues.
Furthermore, during embryonic life, there is a similar tim-
ing for nerve-muscle connections and GLUT4 induction and
GLUT1 repression in rat skeletal muscle (15, 19, 20). These
findings suggest that the regulation of glucose carriers dur-
ing perinatal life might be related to skeletal muscle inner-
vation (15). Muscle denervation is characterized by an im-
pairment of insulin action (21, 22) and a parallel modification
of glucose transporter expression. Thus, GLUT4 markedly
decreases and GLUT1 is enhanced in muscles after resection
of sciatic or peroneal nerves in rats and rabbits (15, 23–25),
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which seems to be a consequence of altered muscular con-
tractile activity (15). The precise intracellular signals that are
triggered by muscle denervation and cause repression of
GLUT4 expression and activation of GLUT1 expression are
unknown. However, there is information indicating that
muscle denervation causes accumulation of intracellular lev-
els of cAMP in muscle and stimulates protein kinase A ac-
tivity (26–28). To determine whether cAMP has a regulatory
role in the expression of glucose carriers in muscle, we have
investigated the effects of cAMP analogs on GLUT1 and
GLUT4 expression in L6E9 muscle cells. These muscle cells
were selected for this study because they express glucose
carriers in a differentiation-dependent manner: myoblasts
mainly express GLUT1, and muscle cell differentiation into
myotubes induces GLUT4 expression (29). Our results indi-
cate that cAMP inversely regulates GLUT1 and GLUT4 ex-
pression in muscle cells and causes a transcriptional activa-
tion of the rat GLUT1 promoter.
Materials and Methods
Materials
[125I]Protein A and [a-32P]deoxy (d)-CTP were purchased from ICN
(Irvine, CA). Hybond-N was obtained from Amersham (Arlington
Heights, IL), and the random primed DNA labeling kit was purchased
from Boehringer Mannheim (Indianapolis, IN). Immobilon was ob-
tained from Millipore Corp. (Bedford, MA). All electrophoresis reagents
and mol wt markers were obtained from Bio-Rad (Richmond, CA) and
BRL (Gaithersburg, MD). g-Globulin, 8-bromo-cAMP, forskolin, 29-O-
monobutyryl-8-bromo-cAMP, T3, and most commonly used chemicals
were purchased from Sigma Chemical Co. (St. Louis, MO). The L6E9 rat
skeletal muscle cell line was provided by Dr. B. Nadal-Ginard (Harvard
University, Boston, MA). DMEM, FBS, glutamine, and antibiotics were
obtained from BioWhittaker (Walkersville, MD).
The plasmid containing the 22212/1164 region of the rat GLUT4
genomic sequence was obtained from Dr. J. Pessin (University of Iowa,
Ames, IA). The plasmid containing the 22106/1134 region of the rat
GLUT1 genomic sequence was obtained from Dr. M. Birnbaum (Uni-
versity of Pennsylvania, Philadelphia, PA). pCAT-Basic and pSV-b-
galactosidase (pSV-b-gal) vectors were obtained from Promega (Mad-
ison, WI). pMT2TRa1 vector containing the thyroid hormone receptor a1
was obtained from Dr. V. Mahdavi (Harvard University) (30).
Cell culture
Rat skeletal muscle L6E9 myoblasts were grown in monolayer culture
in DMEM supplemented with 10% (vol/vol) FBS, 1% (vol/vol) antibi-
otics (10,000 U/ml penicillin G, and 10 mg/ml streptomycin), 2 mm
glutamine, and 25 mm HEPES (pH 7.4). Confluent myoblasts were
differentiated by lowering FBS to a final concentration of 2% (vol/vol).
Preparation of membrane fractions
Cells were washed twice in PBS, scraped, and homogenized in 2 ml
ice-cold buffer containing 25 mm HEPES, 250 mm sucrose, 4 mm EDTA,
1 trypsin inhibitor units/ml aprotinin, 25 mm benzamidine, 0.2 mm
phenylmethylsulfonylfluoride, 1 mm leupeptin, and 1 mm pepstatin, pH
7.4, using a Dounce homogenizer (Kontes Co., Vineland, NJ). After
homogenization, the cell suspension was centrifuged for 10 min at 750 3
g at 4 C. The pellet of the 750 3 g centrifugation showed low contam-
ination with cell surface or intracellular membranes based on the scarce
abundance of glucose transporters. The supernatants were then centri-
fuged at 200,000 3 g for 90 min at 4 C to obtain the membrane fractions.
The membrane pellets were resuspended in homogenization buffer and
repeatedly passed through a 25-gauge needle before storage at 220 C.
Proteins were measured by the method of Bradford (31) using g-globulin
as a standard.
Electrophoresis and immunoblotting of membranes
SDS-PAGE was performed on membrane protein in accordance with
the method of Laemmli (32). Proteins were transferred to Immobilon
(Millipore, Bedford, MA) as previously reported (8) in buffer consisting
of 20% methanol, 200 mm glycine, and 25 mm Tris, pH 8.3. After transfer,
the filters were blocked with 5% nonfat dry milk and 0.02% sodium azide
in PBS for 1 h at 37 C and incubated with antibodies. Transfer was
confirmed by Coomassie blue staining of the gel after the electroblot.
Polyclonal antibody OSCRX (raised against the 15C-terminal peptide
from GLUT4) (33) was used at a 1:400 dilution in 1% nonfat dry milk and
0.02% sodium azide in PBS overnight at room temperature to immu-
noblot GLUT4. Rabbit Bb antiserum raised against the purified human
erythrocyte glucose transporter (a gift from Dr. C. Carter-Su, University
of Michigan) was used at a 1:400 dilution and was incubated with
transferred protein overnight at room temperature in 1% nonfat dry milk
and 0.02% sodium azide in PBS to detect GLUT1. Detection of the
immune complex with the rabbit polyclonal antibodies was accom-
plished using [125I]protein A for 4 h at room temperature. The autora-
diograms were quantified using scanning densitometry. Immunoblots
were performed under conditions in which autoradiographic detection
was in the linear response range.
RNA isolation and Northern blot analysis
Total RNA was extracted using the acid guanidinium thiocyanate-
phenol-chloroform method as described by Chomczynski and Sacchi
(34). All samples had a 260/280 absorbance ratio above 1.8.
After quantification, total RNA (30 mg) was denatured at 65 C in the
presence of formamide, formaldehyde, and ethidium bromide (35) to
allow the visualization of RNA. RNA was separated on a 1.2% agarose/
formaldehyde gel and blotted on Hybond-N filters. The RNA in gels and
filters was visualized with ethidium bromide by UV transillumination
to ensure the integrity of RNA, to check the loading of equivalent
amounts of total RNA, and to confirm proper transfer. RNA was trans-
ferred in 10 3 SSC (1 3 SSC is 0.15 NaCl and 0.015 m sodium citrate, pH
7.0).
Blots were initially prehybridized for 4 h at 45 C in 50% formamide,
5 3 Denhardt’s solution (1 3 Denhardt’s solution is 0.02% polyvinylpy-
rolidone, 0.02% Ficoll, and 0.02% BSA), 0.1% SDS, 5 3 SSPE (1 3 SSPE
is 0.15 m NaCl, 1 mm EDTA, and 10 mm NaH2PO4, pH 7.4), and 0.2
mg/ml denatured salmon sperm DNA. The blots were then hybridized
to the complementary DNA (cDNA) probes for 12 h at 42 C in 50%
formamide, 5 3 Denhardt’s solution, 0.1% SDS, 5 3 SSPE, 10% dextran
sulfate, and 0.2 mg/ml denatured salmon sperm DNA. The rat cDNA
probe for GLUT1 was a 2521-bp fragment, and the rat cDNA probe for
GLUT4 was a 2470-bp EcoRI fragment (both cDNA probes were obtained
from Dr. M. Birnbaum, University of Pennsylvania). The cDNA probes
were labeled with [32P]dCTP by random oligonucleotide priming. The
probes were included at 2 3 106 cpm/ml. Filters were washed for 15 min
in 2 3 SSC at room temperature, then for 20 min in 0.4 3 SSC-0.1% SDS
at 55 C, and finally for 30 min in 0.1 3 SSC-0.1% SDS at 55 C. The
abundance of specific glucose transporter message was quantified by
scanning densitometry of autoradiograms, as described above.
GLUT4 and GLUT1 chloramphenicol acetyltransferase
(CAT) reporter constructs
Plasmid 22106/G1CAT was constructed by inserting a 2240-bp
EcoRI-XhoI fragment containing the rat GLUT1 promoter region from
positions 22106 to 1134 (relative to the transcription start site) into the
XbaI site of pCAT-basic vector (Promega). pCAT-basic was digested
with XbaI, and the ends were filled with dNTPs in the presence of the
Klenow fragment and treated with alkaline phosphatase. The GLUT1
promoter DNA fragment was filled in the presence of dNTPs and Kle-
now fragment and ligated to the pCAT-basic vector. 59-Deletions were
generated by cleavage with SmaI at 2201 (2201/G1CAT) or with AocI
at 299 (299/G1CAT), and adding Klenow and T4 DNA ligase. The
233/G1CAT construct was generated by obtaining a 28-bp HindIII-
BssHII DNA containing the fragment 238/215 from a 106-bp AvaII
fragment (position 238/168) of the GLUT-1 promoter subcloned in
Bluescript. The 28-bp fragment was subcloned into the BssHII site of the
BssHII-G1CAT construct (215/1134).
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Plasmid 22212/G4CAT was generated by subcloning a 2400-bp
EcoRI-BamHI fragment containing the rat GLUT4 promoter region from
positions 22212 to 1152 into the XbaI site of pCAT-basic vector.
Transient transfection
L6E9 cells (n 5 250,000) were grown in 10-mm diameter plates for 2
days in DMEM with 10% FBS. Monolayers were washed in PBS, and
DNA transfection was performed by using the CaPO4 coprecipitation
procedure (36). One milliliter of calcium phosphate DNA precipitate
containing 10 mg of various deletion promoter-CAT constructs, 5 mg
pSV-b-gal control vector (Promega), and 20 mg Bluescript DNA (pSK2,
Stratagene, La Jolla, CA) was added dropwise to the plate. After 16 h,
the cells were washed and incubated with 1 ml 15% glycerol in HEPES-
buffered saline for 3 min, washed in DMEM, and incubated in fresh
complete medium for 72 h. For the myotubes, the medium was changed
to differentiation medium (DMEM supplemented with 2% FBS) after
incubation with the DNA precipitate. 8-Bromo-cAMP (1 mm) was added
48 h before cells were harvested.
Preparation of cell extracts and measurement of CAT
activity
The cells were washed twice in PBS and harvested by scraping in 1
ml STE (10 mm Tris-HCl, pH 7.5, containing 100 mm NaCl and 1 mm
EDTA). The cells were collected by centrifugation in a microcentrifuge
for 10 min, and the pellet was resuspended in 200 ml 0.25 m Tris, pH 7.5.
The cells were lysed by three cycles of freezing and thawing at 37 C. After
centrifugation in a microcentrifuge for 5 min at 4 C, the supernatant was
stored at 220 C.
The CAT activity of 75 ml cytoplasmic extract was measured by
incubating 0.1 mCi [14C]chloramphenicol, 1.3 mm acetyl coenzyme A, 200
mm Tris-HCl (pH 7.5), and the soluble extract for 3.5 h at 37 C. At the
end of the incubation, extraction into ethyl acetate and TLC (37) were
performed. CAT activity was quantitated using an InstantImager (Pack-
ard, Downers Grove, IL). b-Gal activity was measured as previously
described (38). The CAT activity was expressed as a function of b-gal
activity in the same volume of cell lysate.
Results
cAMP analogs repress GLUT4 expression in muscle cells
To test the hypothesis that raising the intracellular cAMP
level causes down-regulation of GLUT4 and up-regulation of
GLUT1, myoblast and myotube L6E9 cells were treated with
cAMP analogs or forskolin. In parallel and as a control,
studies were also performed in the presence of insulin, which
has been reported to regulate GLUT4 and GLUT1 expression
in L6 muscle cells in culture (39).
L6 and L6E9 muscle cells in culture express GLUT4 after
muscle cell differentiation, and this parallels a greater stim-
ulatory effect of insulin (29, 40). In consequence, L6E9 myo-
tubes were treated with 1 mm 8-bromo-cAMP. Twenty-four
and 48 h after treatment, cells were processed to obtain total
membrane proteins, and GLUT4 protein levels were deter-
mined. Western blot assays indicated that 8-bromo-cAMP
treatment for 24 or 48 h caused a substantial progressive
decrease in GLUT4 proteins levels (near 25% and 57% de-
creases after 24 or 48 h of treatment, respectively; Fig. 1A).
Similar results were obtained after treatment for 24 h with 50
mm forskolin (27% decrease) or treatment for 48 h in the
presence of monobutyryl-8-bromo-cAMP (62% decrease)
(data not shown). Treatment with cAMP analogs or forskolin
did not alter the yield of total membrane protein, and in fact,
similar effects were observed when the abundance of GLUT4
was expressed per total membrane fraction (data not shown).
Northern blot assays also revealed a 39% decrease in
GLUT4 messenger RNA (mRNA) levels after 24 h of treat-
ment in the presence of 8-bromo-cAMP (Fig. 1B). Under these
conditions, insulin treatment for 24 h also decreased GLUT4
mRNA levels by 37% (Fig. 1B), which is in agreement with
previous observations obtained in L6 muscle cells (39). This
pattern of changes in response to 8-bromo-cAMP treatment
occurred in the absence of alterations in the yield of total
RNA (data not shown). In all, these results indicate that
8-bromo-cAMP causes a pretranslational repression of
GLUT4 expression in L6E9 myotubes. We next attempted to
determine whether 8-bromo-cAMP treatment modified the
half-life of GLUT4 mRNA in muscle cells. To this end, cells
were treated with actinomycin D (10 mg/ml) for up to 8 h,
and GLUT4 mRNA was determined in control cells or in cells
previously treated with 8-bromo-cAMP. Under our experi-
FIG. 1. Effect of 8-bromo-cAMP or insulin on the expression of
GLUT4 in L6E9 muscle cells. L6E9 myotubes either were not treated
(C) or were treated with 1 mM 8-bromo-cAMP for the indicated times
(for 48 h if not indicated) or with 1 mM insulin for 24 h. After this time,
membrane proteins or total RNA were obtained. A, Twenty-five mi-
crograms of membrane proteins from the different experimental
groups were applied to the gels. After blotting, GLUT4 protein was
detected by incubation with polyclonal antibody OSCRX. B, Thirty
micrograms of total RNA from the different experimental groups were
applied to the gels. The integrity and the relative amounts of RNA in
each sample were checked by ethidium bromide staining on the same
gel (Et Br). After blotting, GLUT4 mRNA was detected after hybrid-
ization with a 2470-bp EcoRI fragment as a cDNA probe, as described
in Materials and Methods. Autoradiographs were subjected to scan-
ning densitometry. Representative autoradiograms from three inde-
pendent experiments are shown. The effects of 8-bromo-cAMP or
insulin were statistically significant (P , 0.05).
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mental conditions, GLUT4 mRNA levels were stable, and
even after 8 h in the presence of actinomycin D no decrease
in GLUT4 mRNA levels was detectable in control and 8-bro-
mo-cAMP-treated groups (data not shown). Longer treat-
ment of cells with actinomycin D resulted in decreased vi-
ability, so measurements of GLUT4 mRNA levels were not
performed. These results, although not providing the precise
half-life of GLUT4 transcripts, suggest that 8-bromo-cAMP
does not substantially modify the stability of GLUT4 mRNA
in muscle cells.
To determine whether the effect of 8-bromo-cAMP in-
volved repression of GLUT4 gene transcription, the 59-reg-
ulatory region of the rat GLUT4 gene, containing 2212 bp of
upstream GLUT4 sequences relative to the transcription start
site and fused to the CAT reporter gene (22212/G4CAT),
was transiently transfected to L6E9 cells and allowed to
differentiate into multinucleated myotubes. This fragment of
the rat GLUT4 promoter contains the elements necessary for
both myotube-specific GLUT4 expression and thyroid hor-
mone responsiveness (41). Transfection of 22212/G4CAT
led to a 5-fold increase in CAT activity compared with that
in cells transfected with the promoterless pCAT-basic vector.
In keeping with previous findings (41), the transcriptional
activity of the GLUT4 gene was highly sensitive to thyroid
hormone. Thus, transfection of 22212/G4CAT in the absence
of thyroid hormones caused a 64% decrease in CAT activity
(Fig. 2). Furthermore, cotransfection of 22212/G4CAT and
thyroid hormone receptor a1 led to a 3.8-fold increase in CAT
activities in the presence of T3 for 48 h (Fig. 2). In parallel
assays, L6E9 cells at different cell densities were transfected
with 22212/G4CAT and treated or not with 1 mm 8-bromo-
cAMP for different periods. No change in CAT activity due
to 8-bromo-cAMP treatment was detected under any of these
conditions (Fig. 2 and data not shown). These results suggest
that if 8-bromo-cAMP induces GLUT4 gene repression, this
requires the participation of cis elements located outside the
2212-bp fragment of the rat GLUT4 promoter used in this
study.
8-Bromo-cAMP enhances GLUT1 expression in muscle cells
We also assessed the effect of 8-bromo-cAMP, forskolin, or
insulin on the expression of GLUT1 in L6E9 muscle cells. As
both L6E9 myoblasts and myotubes express GLUT1, we
studied the effects of the above-mentioned agents on GLUT1
expression in L6E9 cells before and after myogenic differ-
entiation. We should note that the results obtained in
myotubes correspond to the same samples as those shown in
Fig. 1.
In L6E9 myoblasts, treatment with 8-bromo-cAMP (1 mm),
forskolin (50 mm), or insulin (1 mm) led to a marked increase
in GLUT1 protein content (from 2- to 3.6-fold increase; Fig.
3A and data not shown). Similarly, treatment of L6E9 myo-
tubes in the presence of 8-bromo-cAMP for 24 or 48 h or in
the presence of insulin for 24 h caused a substantial increase
in GLUT1 protein levels (1.6- and 1.7-fold increase after 24 or
48 h of 8-bromo-cAMP treatment, respectively, and 3.1-fold
increase after insulin treatment; Fig. 3B). The increase in
GLUT1 protein content in response to 8-bromo-cAMP or
forskolin treatment occurred in the presence of a similar yield
of membrane protein, and in consequence, similar effects
were observed when the abundance of GLUT1 was ex-
pressed per total membrane fraction (data not shown).
To determine the mechanism for the enhanced GLUT1
expression, we obtained total RNA from L6E9 cells treated
or not with 8-bromo-cAMP or insulin, and Northern blot
assays were performed with a probe specific for GLUT1. The
results shown in Fig. 4 reveal an enhanced GLUT1 mRNA
expression after treatment with 8-bromo-cAMP (2.2-fold in-
crease) or insulin (4-fold increase) in L6E9 myoblasts (Fig.
4A). Insulin treatment for 24 h led to a 40% increase in GLUT1
mRNA levels in L6E9 myotubes (Fig. 4B). In contrast, no
stimulatory effect of 8-bromo-cAMP on GLUT1 mRNA levels
was detected in L6E9 myotubes (Fig. 4B).
These results suggest a different pattern of effects of
8-bromo-cAMP in myoblasts and myotubes; whereas 8-bro-
mo-cAMP induces GLUT1 expression in myoblasts at a
pretranslational level, the 8-bromo-cAMP-induced GLUT1
expression in myotubes is a consequence of activation at
translational or posttranslational steps. To assess whether the
stimulatory effect of 8-bromo-cAMP on GLUT1 mRNA levels
in myoblasts results from changes in the rates of gene tran-
scription, the 59-regulatory region of the rat GLUT1 gene
FIG. 2. Effect of 8-bromo-cAMP or thyroid hormones on CAT activity
driven by GLUT4 promoter in transfected L6E9 myotubes. A, L6E9
myotubes were transiently cotransfected by calcium phosphate pre-
cipitation with the 22212/G4CAT construct (10 mg), pMT2TRa1 en-
coding the rat thyroid hormone receptor a1 (10 mg) and with pSV-b-gal
(10 mg) as indicated. Cells were allowed to differentiate in T3-depleted
medium in the absence or presence of 50 nM T3. In parallel, cells
maintained in normal medium were transfected with the 22212/
G4CAT construct (10 mg) or with pSV-b-gal (10 mg; C). B, L6E9
myotubes were transiently cotransfected by calcium phosphate pre-
cipitation with the 22212/G4CAT construct (10 mg) and with pSV-
b-gal (5 mg) as indicated. Sixteen hours after transfection, cells were
transferred to differentiation medium for 48 h in the absence (C) or
presence of 1 mM 8-bromo-cAMP and harvested as myotubes. Auto-
radiographs were subjected to scanning densitometry, and represen-
tative autoradiograms are shown. Data are also presented as the
relative CAT activity/b-gal activity (mean) in four to six experiments
performed in duplicate using at least two preparations of each DNA
construct.
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containing 2106 bp upstream GLUT1 sequence relative to the
transcription start site and fused to the CAT reporter gene
(22106/G1CAT) was transiently transfected to L6E9 myo-
blasts. This transfection led to an 11.5-fold increase in CAT
activity in soluble extracts compared with that in cells trans-
fected with the promoterless pCAT-basic vector (Fig. 5).
These cells were treated or not with 8-bromo-cAMP for 48 h
or with insulin for 24 h, and thereafter CAT activity was
determined. The results shown in Fig. 5 also indicate that
CAT activity was markedly enhanced (1.9-fold increase) in
myoblast L6E9 cells treated with 8-bromo-cAMP. Under
these conditions, insulin did not affect the transcriptional
activity of the GLUT1 gene (data not shown). These results
indicate a regulatory element within the 2.1 kilobases (kb) of
the GLUT1 promoter that confer sensitivity to 8-bromo-
cAMP by stimulating transcriptional activity in L6E9 myo-
blasts. The extent of stimulation caused by 8-bromo-cAMP
on the transcriptional activity of the rat GLUT1 gene pro-
moter was very similar to the enhancement of GLUT1 mRNA
levels.
Identification of a promoter region of GLUT1 gene required
for up-regulation of transcription in response to
8-bromo-cAMP
The regulatory element(s) within the GLUT1 gene respon-
sible for cAMP-induced transcriptional activation in L6E9
myoblasts was dissected out by 59-deletions of the rat GLUT1
promoter and transfected into L6E9 myoblasts. Deletion
from 22106 to 2812 of the GLUT1 gene caused no significant
alterations in CAT activity (data not shown), and deletion
from 2812 to 2201 caused nearly a 3.8-fold stimulation of
CAT activity (data not shown). The transcriptional activity of
the 2201 construct was maximal, and only a slight decrease
was noted after deletion from 2201 to 299 (Fig. 6). However,
deletion of an additional 66 bp (from 299 to 233) led to a
marked reduction (80%) in the transcriptional activity
(Fig. 6).
To assess the effect of truncating the GLUT1 promoter on
cAMP-induced transcriptional induction, myoblasts tran-
siently transfected with a series of GLUT1 promoter-CAT
59-deletion mutants were treated or not with 8-bromo-cAMP
for 48 h and further analyzed. The results shown in Fig. 6
demonstrate that CAT activity was markedly activated by
cAMP in cells transfected with all of the constructs studied.
The extent of the activation ranged from a 1.8- to 2.3-fold
increase (Fig. 6). The maximal stimulatory effect of 8-bromo-
cAMP was found in the 2201CAT and 299CAT constructs
(Fig. 6); however, the effect of 8-bromo-cAMP was still
clearly detectable in 233CAT, a construct that contains the
TATA box of the GLUT1 promoter and the transcription start
site. Deletions of up to 151 bp in the 39-end of the fragment
22106/1134 of the 22106/G1CAT construct did not elim-
inate the stimulatory effect of 8-bromo-cAMP (data not
shown), suggesting that the cAMP response elements do not
lie 39 of the transcriptional start site.
In all, these results indicate a fragment located between
299 and 233 bp of the initiation transcription site that con-
fers transcriptional activity of the rat GLUT1 gene in myo-
blast cells. Furthermore, our data indicate that 8-bromo-
cAMP stimulates the transcriptional activity of the rat
GLUT1 promoter, which requires the 33 bp lying 59 upstream
of the transcription start site.
Discussion
The results of the present study indicate that cAMP has a
marked influence on the expression of glucose carriers in
muscle cells. Thus, treatment with cAMP analogs or the
activator of adenylate cyclase, forskolin, reduces GLUT4 ex-
pression and increases GLUT1 expression in L6E9 muscle
cells. In myoblasts, cAMP stimulates the transcriptional ac-
tivity of the rat GLUT1 promoter and a 33-bp sequence lying
59 upstream of the transcription start site is required for the
effects of 8-bromo-cAMP. In general, the effects of cAMP on
glucose transporter expression are similar to the effects of
FIG. 3. Effect of 8-bromo-cAMP or insulin on the expression of GLUT1 protein in L6E9 muscle cells. L6E9 myoblasts (A) or myotubes (B) either
were treated with 1 mM 8-bromo-cAMP for the indicated times (for 48 h if not indicated) or with 1 mM insulin for 24 h, after which total membrane
proteins were obtained. Twenty-five micrograms of membrane proteins from the different experimental groups were applied to the gels. After
blotting, GLUT1 protein was detected by incubation with a polyclonal antibody. Autoradiographs were subjected to scanning densitometry.
Representative autoradiograms from three independent experiments are shown. The arrows indicate the bands that correspond to GLUT1
protein. Values for the 8-bromo-cAMP and insulin groups were statistically significant (P , 0.05).
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prolonged administration of insulin in muscle cells (Refs. 39,
42, and 43 and this study). Nevertheless, the mechanisms that
activate GLUT1 in response to cAMP and insulin are differ-
ent, as cAMP, but not insulin, increases the transcriptional
activity of 2.1 kb of the rat GLUT1 promoter.
Here we found that GLUT4 expression is markedly in-
hibited by 8-bromo-cAMP, monobutyryl-8-bromo-cAMP, or
forskolin. Regarding the mechanisms involved, we detected
reduced levels of GLUT4 mRNA that were already apparent
after 24 h of 8-bromo-cAMP treatment, indicating changes at
a pretranslational step. Furthermore, no modification of
GLUT4 mRNA levels was detected even after 8 h of treatment
with actinomycin D in control or 8-bromo-cAMP-treated
myotubes, which indicates that the stability of the GLUT4
transcripts is high in myotubes under both conditions and,
therefore, favors an action of 8-bromo-cAMP at the level of
gene transcription. We also analyzed the effect of 8-bromo-
cAMP on the transcriptional activity of a 2.2-kb fragment of
the rat GLUT4 gene, which contains the elements necessary
for both myotube-specific GLUT4 expression and thyroid
hormone responsiveness in muscle cells (41, 44) and response
to streptozotocin-induced diabetes in transgenic mice (45).
Our results did not reveal any inhibitory effect of 8-bromo-
cAMP under conditions in which we substantiated sensitiv-
ity to thyroid hormones. If indeed cAMP induces GLUT4
gene repression, the cis-acting elements involved in the re-
sponse to cAMP must lie in a fragment other than the 2.1-kb
59 flanking the rat GLUT4 gene. A cAMP-responsive frag-
ment of the mouse GLUT4 gene located between positions
2469 and 278 has been identified after transfection into
3T3-L1 adipocytes (46). This suggests a tissue-specific mech-
anism involved in the regulation of GLUT4 in response to
cAMP.
In this study, we have shown that insulin enhances GLUT1
expression and represses GLUT4 in L6E9 muscle cells. These
effects are in keeping with previous findings reported in L6
muscle cells (39) and 3T3-L1 adipocytes (47). These results
are in contrast to in vivo studies in which the acute infusion
FIG. 4. Effect of 8-bromo-cAMP or insulin on the expression of
GLUT1 mRNA in L6E9 muscle cells. L6E9 myoblasts (A) or myotubes
(B) were not treated (C) or were treated with 1 mM 8-bromo-cAMP for
48 h or with 1 mM insulin for 24 h, after which total RNA was isolated.
Thirty micrograms of total RNA from the different experimental
groups were applied to the gels. The integrity and the relative
amounts of RNA in each sample were checked by ethidium bromide
staining on the same gel (Et Br). After blotting, GLUT1 mRNA was
detected after hybridization with a 2521-bp EcoRI fragment as a
cDNA probe, as described in Materials and Methods. Autoradiographs
were subjected to scanning densitometry. Representative autoradio-
grams from three independent experiments are shown. Treatment of
8-bromo-cAMP in myoblasts and treatment of insulin in myoblasts
and myotubes caused statistically significant effects on GLUT1
mRNA levels (P , 0.05).
FIG. 5. Effect of 8-bromo-cAMP or insulin on CAT activity driven by
GLUT1 promoter in transfected L6E9 myoblasts. A, L6E9 myoblasts
were untransfected (2) or transiently cotransfected by calcium phos-
phate precipitation with the 22,106/G1CAT promoter construct (10
mg) or with the promoterless pCAT-basic vector (10 mg) and with
pSV-b-gal (5 mg) as indicated. B, L6E9 myoblasts were transfected
with the 22,106/G1CAT construct, and then incubated in growth
medium for 48 h in the absence (2) or presence of 1 mM 8-bromo-cAMP
(1) and harvested as myoblasts. Autoradiographs were subjected to
scanning densitometry. Representative autoradiograms are shown.
The data are also expressed as the relative CAT activity/b-gal activity
(mean) in four to six experiments. These results were obtained from
transfection experiments, performed in duplicate, using at least two
preparations of DNA.
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of insulin enhances GLUT4 mRNA levels in human muscle
(48). It is likely that these contradictory data are explained by
a different effect of insulin in cultured myotubes and muscle
fibers or by possible differences due to acute or chronic
exposure to insulin.
cAMP exerts a stimulatory effect on GLUT1 expression in
L6E9 muscle cells as a consequence of the triggering of sep-
arate mechanisms in myoblasts and myotubes. Thus, cAMP
stimulates GLUT1 protein and mRNA and the transcrip-
tional activity of rat GLUT1 promoter in myoblasts; however,
cAMP up-regulates GLUT1 protein in the absence of changes
in mRNA levels, suggesting stimulation at a posttranscrip-
tional level. Furthermore, we identified a promoter region of
GLUT1 gene that contains cis elements responsible for cAMP
responsiveness in myoblast cells. Studies of transient trans-
fection with 59-deletion constructs of the rat GLUT1 gene
indicate that cAMP stimulates the transcriptional activity of
the rat GLUT1 promoter through 33 bp lying 59 upstream of
the transcription start site. This fragment of the rat GLUT1
promoter contains the TATA box and shows very low tran-
scriptional activity. This suggests that cAMP might stimulate
GLUT1 gene transcription through enhancement of the basal
transcriptional machinery. Similar to our data, it has been
reported that a fragment (238/1138) located in the proximal
promoter of the carbamoyl-phosphate synthetase I gene,
which contains only the TATA box motif, is capable of re-
sponding to cAMP by enhancing transcriptional activity (49).
Furthermore, it was recently reported that myogenic regu-
latory factors seem to interact with the basal transcription
machinery of the skeletal muscle myosin heavy chain gene
(50). Whether the effect of cAMP on transcriptional activation
of GLUT1 requires the TATA motif of the rat GLUT1 gene
should be determined.
We have also identified a fragment located between 299
and 233 bp of the initiation start site that confers transcrip-
tional activity in the rat GLUT1 promoter. Whether this frag-
ment is also involved in the response to 8-bromo-cAMP
remains to be determined. Although the specific DNA ele-
ments involved in the response to cAMP are unknown, in-
spection of the 99 bp lying 59 upstream of the transcription
start site reveals the absence of cAMP-regulatory elements
and the presence of some putative cis elements (51). Thus,
there is an Sp1 element in the 59-end of this fragment and two
separate activating protein-2-like elements as well as a CAAT
box element toward the 39-end. Whether some of these ele-
ments, namely the activating protein-2-like elements that are
found in a number of cAMP-responsive genes that lack
cAMP regulatory elements (52), are involved in the effect of
cAMP remains unknown. Gel retardation analysis are un-
derway to identify the specific DNA sequences involved and
the possible regulatory proteins responsible for activation of
GLUT1 gene transcription. Based on studies performed with
the mouse GLUT1 gene, the activities of two different en-
hancers of the GLUT1 gene have been reported (53). These
two enhancers have not been characterized in the rat GLUT1
gene, and therefore, their participation in the response to
cAMP remains to be determined. In this regard, it has been
reported that the stimulatory effect of insulin on GLUT1 gene
expression in NIH/3T3 fibroblasts indeed requires the pres-
ence of these two enhancers (54).
The effects of cAMP on glucose transporter expression are
similar in adipocytes and muscle cells. Thus, it has been
reported that exposure to 8-bromo-cAMP enhances GLUT1
and represses GLUT4 expression in 3T3-L1 adipocytes (55),
in agreement with this work. The role of cAMP controlling
glucose transporter expression in adipocytes explains the
changes in glucose transporter expression in adipose tissue
during experimental diabetes, in which enhanced cAMP lev-
els have been detected (56) in parallel with a marked deple-
tion of GLUT4 content (8, 57–60). The effect of cAMP on the
regulation of glucose transporter expression may be relevant
to skeletal muscle in vivo, where GLUT4 is the major glucose
transporter isoform. Thus, cAMP levels rise after denerva-
tion in skeletal muscle (26–28) a situation in which GLUT1
expression increases and GLUT4 is repressed (15, 23–25);
similarly, cAMP concentrations are high in skeletal muscle at
FIG. 6. Effect of 8-bromo-cAMP on the expression of GLUT1 59-de-
letion constructs in L6E9 myoblasts. A series of 59-deletions of the
upstream region of the GLUT1 gene from 22106 to 233 bp relative
to the transcription start site was generated as indicated. L6E9 myo-
blasts were transiently transfected with the various constructs. After
transfection, cells were incubated in growth medium for 48 h in the
absence (open bars) or presence of 1 mM 8-bromo-cAMP (hatched bars)
and harvested as myoblasts. The data are expressed as the relative
CAT activity/b-gal activity 6 SEM from four to six experiments, with
the 22016/G1CAT construct being set at a value of 100. These results
were obtained from transfection experiments performed in duplicate
using at least two preparations of DNA. Differences between control
and 8-bromo-cAMP groups were statistically significant (P , 0.05).
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birth and drop during neonatal life (61), when there is a
transition regarding the expression of glucose carriers in
muscle, so GLUT1 is repressed and GLUT4 is induced (14,
15). Our results together with the above-mentioned obser-
vations favor the view that cAMP plays an important role in
regulating GLUT1 and GLUT4 expression after denervation
or during perinatal life in skeletal muscle. Furthermore, it has
been reported that increased cAMP concentrations inhibit
myogenic differentiation and the activity of the muscle-spe-
cific helix-loop-helix transcription factors in C2C12 and L6
cells (62). In this regard, it will be of interest to assess whether
myogenic factors are involved in the cAMP-induced regu-
lation of GLUT1 and GLUT4 expression.
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29. Kaliman P, Viñals F, Testar X, Palacı́n M, Zorzano A 1996 Phosphatidylino-
sitol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol
Chem 271:19146–19151
30. Lee Y, Mahdavi V 1993 The D domain of the thyroid hormone receptor a1
specifies positive and negative transcriptional regulation functions. J Biol
Chem 268:2021–2028
31. Bradford MM 1976 A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem 72:248–254
32. Laemmli UK 1970 Cleavage of structural protein during tha assembly of the
head of bacteriophage T4. Nature 227:680–685
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